- Sections
- C - Chimiemétallurgie
- C12N - Micro-organismes ou enzymescompositions les contenantculture ou conservation de micro-organismestechniques de mutation ou de génétiquemilieux de culture
- C12N 15/24 - Interleukines
Détention brevets de la classe C12N 15/24
Brevets de cette classe: 280
Historique des publications depuis 10 ans
|
7
|
6
|
4
|
7
|
9
|
11
|
12
|
22
|
17
|
5
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Trustees of the University of Pennsylvania | 4374 |
7 |
| Regeneron Pharmaceuticals, Inc. | 4377 |
6 |
| Altor BioScience, LLC | 76 |
6 |
| Joint Stock Company "BIOCAD" | 192 |
5 |
| Noile-immune Biotech Inc. | 35 |
5 |
| Board of Regents, The University of Texas System | 5906 |
4 |
| National University Corporation Tottori University | 204 |
4 |
| National University of Singapore | 2491 |
4 |
| Shenzhen Institutes of Advanced Technology Chinese Academy of Sciences | 2064 |
4 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2892 |
4 |
| University Health Network | 1056 |
4 |
| Yale University | 2424 |
4 |
| Nanjing Bioheng Biotech Co., Ltd | 45 |
4 |
| Novartis AG | 10685 |
3 |
| Boehringer Ingelheim International GmbH | 4632 |
3 |
| Merck Patent GmbH | 5770 |
3 |
| Children's Healthcare of Atlanta, Inc. | 247 |
3 |
| Emory University | 1646 |
3 |
| Ottawa Hospital Research Institute | 108 |
3 |
| St. Jude Children's Research Hospital, Inc. | 225 |
3 |
| Autres propriétaires | 198 |